Patents Represented by Attorney Sidney B. Williams, Jr.
  • Patent number: 4412993
    Abstract: Prophylactic and therapeutic methods of treating pseudopregnancy and galactorrhea in mammals with 7.alpha.-methyltestosterones. Also, use of 7.alpha.-methyltestosterones in adjunct treatment of mastitis in mammals.
    Type: Grant
    Filed: January 28, 1981
    Date of Patent: November 1, 1983
    Assignee: The Upjohn Company
    Inventor: James H. Sokolowski
  • Patent number: 4413013
    Abstract: Novel pesticidal N-[[[arylformimidoyl]methylamino]thio]-N-substituted sulfonamides are disclosed with novel compositions thereof and methods for their use in controlling invertebrate arthropod pests, particularly insects, mites, and ticks.
    Type: Grant
    Filed: December 14, 1981
    Date of Patent: November 1, 1983
    Assignee: The Upjohn Company
    Inventor: Victor L. Rizzo
  • Patent number: 4405796
    Abstract: This invention pertains to novel processes for preparing phosphorus derivatives of aminothiomethylcarbamates using as intermediates corresponding phosphorus derivatives of aminothiocarbamic halides. The carbamates are useful as pesticides against insects, mites, and nematodes. Two processes for preparing the corresponding intermediates are described. One preparation generally reacts an appropriate N-chlorothiophosphoramide with N-methylcarbamoyl halide. The other preparation generally reacts an N-chlorothiomethylcarbamoyl halide with an appropriate phosphoramide. The intermediate will react with various alcohols to produce the desired carbamates in the process of the invention.
    Type: Grant
    Filed: March 8, 1982
    Date of Patent: September 20, 1983
    Assignee: The Upjohn Company
    Inventor: Stephen J. Nelson
  • Patent number: 4400524
    Abstract: A process for preparing 19-norandrostenedione. Also provides key intermediates of 19-norandrostenedione and methods for preparing them in high yields.
    Type: Grant
    Filed: September 15, 1981
    Date of Patent: August 23, 1983
    Assignee: The Upjohn Company
    Inventor: Joel E. Huber
  • Patent number: 4398035
    Abstract: The invention concerns the novel compounds dialkyl 2-(3-fluoro-4-nitrophenyl)-2-methylmalonate IIIa and dialkyl 2-(3-fluoro-4-aminophenyl)-2-methylmalonate IVa useful as intermediates in an improved process for making 2-(2-fluoro-4-biphenylyl)propionic acid, known as flurbiprofen, having the formula ##STR1## and ester thereof. It has anti-inflammatory activity which is about 240 times that of aspirin and analgesic activity which is about 180 times that of aspirin in standard laboratory tests. However, despite this high activity, the toxicity (LD.sub.50) is only 1.2 to 2.4 times greater than that of aspirin in standard laboratory tests.Also within the invention is a novel method of making the above intermediates and analogs thereof useful to prepare corresponding biaryl compounds which have pharmaceutical uses.
    Type: Grant
    Filed: October 3, 1980
    Date of Patent: August 9, 1983
    Assignee: The Upjohn Company
    Inventor: Jerry A. Walker
  • Patent number: 4380652
    Abstract: A method for the preparation of 6'-methylspectinomycin and analogs thereof. Additionally provides novel intermediates utilized in said method.
    Type: Grant
    Filed: July 20, 1981
    Date of Patent: April 19, 1983
    Assignee: The Upjohn Company
    Inventor: David R. White
  • Patent number: 4380651
    Abstract: A method for the preparation of 6'-methylspectinomycin and analogs thereof. Additionally provides novel intermediates utilized in said method.
    Type: Grant
    Filed: July 20, 1981
    Date of Patent: April 19, 1983
    Assignee: The Upjohn Company
    Inventor: David R. White
  • Patent number: 4361701
    Abstract: Anomers and asteric mixtures of novel analogs of spectinomycin. Additionally provides novel intermediates and process for preparing spectinomycin analogs.
    Type: Grant
    Filed: March 13, 1979
    Date of Patent: November 30, 1982
    Assignee: The Upjohn Company
    Inventor: David R. White
  • Patent number: 4354975
    Abstract: This invention pertains to novel processes for preparing phosphorus derivatives of aminothiomethylcarbamates using as intermediates corresponding phosphorus derivatives of aminothiocarbamic halides. The carbamates are useful as pesticides against insects, mites, and nematodes. Two processes for preparing the corresponding intermediates are described. One preparation generally reacts an appropriate N-chlorothiophosphoramide with N-methylcarbamoyl halide. The other preparation generally reacts an N-chlorothiomethylcarbamoyl halide with an appropriate phosphoramide. The intermediate will react with various alcohols to produce the desired carbamates in the process of the invention.
    Type: Grant
    Filed: July 21, 1980
    Date of Patent: October 19, 1982
    Assignee: The Upjohn Company
    Inventor: Stephen J. Nelson
  • Patent number: 4352805
    Abstract: Isochromans, isothiochromans, 2-benzoxepins and 2-benzothiepins are described. The compounds possess hypotensive and antipsychotic properties; methods and compositions using them are described.
    Type: Grant
    Filed: October 10, 1980
    Date of Patent: October 5, 1982
    Assignee: The Upjohn Company
    Inventor: John M. McCall
  • Patent number: 4352929
    Abstract: Novel cyclized .omega.-carboxyethyl mono- or dithiocarbanilic acids are disclosed as immunoregulatory agents, useful in the treatment of organ transplant reject phenomenon and autoimmune diseases particularly where a delayed hypersensitivity component has been established, such as multiple sclerosis.Additionally described is the use of certain cyclized .omega.-carboxyalkyl mono- or dithiocarbamic acids and certain cyclized .omega.-carboxyalkyl mono- or dithiocarbamic acids.
    Type: Grant
    Filed: May 29, 1981
    Date of Patent: October 5, 1982
    Assignee: The Upjohn Company
    Inventors: David J. Anderson, Barbara E. Loughman
  • Patent number: 4351771
    Abstract: Anomers and asteric mixtures of novel analogs of spectinomycin. Additionally provides novel intermediates and process for preparing spectinomycin and analogs thereof.
    Type: Grant
    Filed: May 16, 1980
    Date of Patent: September 28, 1982
    Assignee: The Upjohn Company
    Inventors: David R. White, Richard C. Thomas
  • Patent number: 4345086
    Abstract: Process for preparing intermediates of spectinomycin and analogs thereof. Also provides novel intermediates for making spectinomycin and analogs thereof.
    Type: Grant
    Filed: December 4, 1980
    Date of Patent: August 17, 1982
    Assignee: The Upjohn Company
    Inventor: David R. White
  • Patent number: 4344882
    Abstract: Process for preparing intermediates of spectinomycin and analogs thereof. Also provides novel intermediates for making spectinomycin and analogs thereof.
    Type: Grant
    Filed: December 4, 1980
    Date of Patent: August 17, 1982
    Assignee: The Upjohn Company
    Inventor: David R. White
  • Patent number: 4343799
    Abstract: Use of water soluble 21-polybasic esters of 1-dehydro-6.alpha.-methylhydrocortisone and their salts for the prevention and treatment of cardiotoxicity induced by Adriamycin chemotherapy.
    Type: Grant
    Filed: March 20, 1981
    Date of Patent: August 10, 1982
    Assignee: The Upjohn Company
    Inventor: Jay W. Heckler
  • Patent number: 4340602
    Abstract: An estrogen sulfotransferase inhibitor composition comprises a compound of the formula ##STR1## wherein R.sub.1 is Br, NO.sub.2, or H; R.sub.2 is Br, NO.sub.2, NH.sub.2, or H; R is H or alkyl of 1-4 carbon atoms; R.sub.3 is O or H.sub.2 ; and R.sub.4 is H.sub.2, O, or .alpha.-H, .beta.-OH, in admixture with a pharmaceutically acceptable carrier. The specificity of the invention is believed targeted to the substituent at R.sub.2 or C.sub.4 and secondarily the OR group at C.sub.3.
    Type: Grant
    Filed: October 18, 1978
    Date of Patent: July 20, 1982
    Assignee: Wayne State University
    Inventor: Samuel C. Brooks
  • Patent number: 4337347
    Abstract: Process for preparing intermediates of spectinomycin and analogs thereof. Also provides novel intermediates for making spectinomycin and analogs thereof.
    Type: Grant
    Filed: December 4, 1980
    Date of Patent: June 29, 1982
    Assignee: The Upjohn Company
    Inventor: David R. White
  • Patent number: 4336207
    Abstract: This invention pertains to novel phosphorus derivatives of aminothiocarbamic halides and processes for their preparation. The carbamic halides are readily prepared by two general procedures. In one procedure an appropriate N-(chlorothio)phosphorus amide reactant is readily prepared by reacting the corresponding phosphorus amide with sulfur dichloride which reactant will react with N-methylcarbamoyl halide so as to produce the corresponding object compounds of this invention. In a different procedure the same compounds that are the object of this invention are prepared by reacting an appropriate corresponding phosphorus amide with an N-chlorothiomethylcarbamoyl halide reactant which reactant is readily prepared by reacting N-methylcarbamoyl halide with sulfur chloride. The novel compounds of this invention are intermediates for the preparation of pesticides.
    Type: Grant
    Filed: June 23, 1980
    Date of Patent: June 22, 1982
    Assignee: The Upjohn Company
    Inventor: Stephen J. Nelson
  • Patent number: 4333883
    Abstract: A process for the preparation of N-chlorothio(methyl)carbamoyl halides.
    Type: Grant
    Filed: July 6, 1981
    Date of Patent: June 8, 1982
    Assignee: The Upjohn Company
    Inventor: Stephen J. Nelson
  • Patent number: D267653
    Type: Grant
    Filed: August 11, 1980
    Date of Patent: January 18, 1983
    Assignee: The Upjohn Company
    Inventors: Ronald A. Miller, Robert Korstanje